MedPath

Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma

Recruiting
Conditions
Gene Abnormality
Mesothelioma, Malignant
Pleural Mesothelioma
Registration Number
NCT04823741
Lead Sponsor
Hospices Civils de Lyon
Brief Summary

Malignant pleural mesothelioma (MPM) is a rare pleural cancer, which could be primary or secondary to an asbestos exposure. To enhance our knowledge of this rare disease, an exploration of genetic and tumor mechanism is mandatory. One of the principal difficulty is to harvest sufficient tumour pieces to perform multi-omics analysis. The goal of the SCITH-MESO study is to harvest larges pieces of tumour during a routine surgical procedure of MPM diagnosis by mean of pleural biopsies during VATS surgery. Operating samples will increase a tissue bank collection (CRB).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • age >18
  • suspected MPM requiring VATS biopsy after multidisciplinary oncologic board validation
  • patient able to understand study objectives and able to give an informed consent
  • patient affiliated to an healthcare society.
Exclusion Criteria
  • pregnancy
  • mental disease, psychiatric disorder
  • patient under protection regimen

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
For patients with MPM, blood samples are collected and a piece of biopsy will be used for the constitution of a specific bio collection in the CRB (centre de ressources biologiques).day 1 (day of chirurgie)

For patients with MPM, blood samples are collected and a piece of biopsy will be used for the constitution of a specific bio collection in the CRB (centre de ressources biologiques).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Département de chirurgie thoracique

🇫🇷

Bron, France

Département de chirurgie thoracique
🇫🇷Bron, France
Jean Michel MAURY
Contact
04.72.35.75.90
jean-michel.maury@chu-lyon.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.